AVPT AvePoint, Inc. Insider Trading

CLO Brian Michael Brown sells 40,000 AVPT shares for $525,693.58 under pre-arranged 10b5-1 plan

Brian Michael Brown, Chief Legal Officer, executed two separate sales totaling 40,000 shares for $525,693.58 under a 10b5-1 trading plan adopted on 2025-12-16, reducing his holdings from 859.7K to 819.7K shares (-4.7%). The stock has appreciated +21.6% over the 30-day period and +31.4% over the 90-day period within its 52-week range of $8.84–$19.95, currently at $13.19. His prior sales at AVPT show mixed outcomes: five prior trades recorded 30-day returns of -1.2% to -7.4% and 90-day returns of -9.9% to -17.5%, though this transaction is scheduled under a pre-arranged plan rather than discretionary. The company's fundamentals show revenue of $117.2M, net income of $15.2M, annual revenue growth of +26.9%, and a P/E of 59.95.

Chief Legal Officer Brian Michael Brown sold 35,000 shares at blended avg $15.56 on 2025-09-23; stock down 23.9% from 52-week high.

Brown's 3 separate sales totaling 35,000 shares for $544,618.86 occurred as AVPT trades 23.9% below its 52-week high of $19.99, with 90-day returns of -20.8%. His prior trades at AVPT show 2 of 2 measurable 90-day outcomes were well-timed (negative returns after sale dates), though the latest two sales (2025-09-18 and 2025-08-25) have outcomes not yet measurable. He retains 633,741 shares post-transaction, representing a 5.2% reduction in holdings. The company's fundamentals show revenue growth of 21.6% year-over-year to $102,018,000 in the latest quarter, though full-year net income was negative despite recent quarterly profitability of $2,893,000. The timing of these sales into a declining stock price—coinciding with recent broader weakness—warrants observation of whether this pattern continues or reverses.

CEO Jiang Tianyi sells 2,068,966 shares of AVPT for $31,468,972.86 at $15.21; holdings reduce 13.0%

CEO Jiang Tianyi executed a substantial sale of 2,068,966 shares for $31,468,972.86 at $15.21 per share, reducing his holdings from 15,910,819 to 13,841,853 shares. This represents a 13.0% reduction in his position at a price significantly below the 52-week high of $19.99 (-21.2%), during a period of downward pressure with a 90-day decline of -17.4%. The company shows solid revenue growth of 21.6% annually and achieved net income of $2,893,000.00 in the latest quarter, though it was unprofitable over the most recent full fiscal year. The CEO retains substantial ownership with 13.84M shares post-sale, but the magnitude and execution of this transaction amid the stock's weakened momentum and the company's recent profitability swing warrants investor attention.

Executive Chairman Gong Xunkai sold 2.07M AVPT shares at $15.21 for $31.5M, reducing stake by 12%

Gong Xunkai sold 2,068,966 shares at $15.21 on 2025-09-18, representing a 12.0% reduction in his holdings from 17,289,634 to 15,220,668 shares. The sale occurred at a price 3.4% below the current market price of $15.75 and 23.9% below the 52-week high of $19.99, while the company's stock has declined 17.4% over the past 90 days. Despite a recent 21.6% annual revenue growth rate and a $3.3B market cap, AvePoint remains unprofitable on a full-year basis, with the company generating only $2,893,000 in net income on $102,018,000 in latest quarterly revenue. This material sale by the top executive occurs against a backdrop of recent price weakness and underlying profitability challenges, warranting assessment of whether broader strategic or financial concerns prompted the reduction in the insider's exposure.

CFO James Caci sells 216,000 AVPT shares (50.3% of holdings) for $3.3M at $15.21; stock down 21.2% from 52-week high.

CFO Caci James executed a substantial reduction, selling 216,000 shares (50.3% of pre-transaction holdings) for $3,285,360.00. The sale occurred at $15.21, placing the transaction 23.5% below the 52-week high of $19.99 and below the current price of $15.75. The timing coincides with a 90-day decline of -17.4%, though the company's fundamentals show revenue growth of 21.6% year-over-year and latest quarterly revenue of $102,018,000.00. However, the company was unprofitable over its most recent full fiscal year, which may factor into capital allocation decisions by senior management. The magnitude of this sale — reducing the CFO's stake by approximately half — represents a material shift in insider ownership and warrants investor attention given the broader context of the stock's recent weakness relative to its 52-week range.

Director Ho John Chi On sold 650,000 shares of AVPT at $15.21; holds 3.73M shares remaining (-14.8%).

Ho John Chi On (Director) executed a 650,000-share sale at $15.21 on September 18, 2025, reducing his holdings by 14.8% from 4.38M to 3.73M shares. The sale occurred while AVPT traded 21.2% below its 52-week high of $19.99, and the company reported quarterly revenue of $102.0M (+21.6% annually) despite full-year unprofitability. The directional significance of a director liquidating nearly 15% of his position merits attention in context of the company's profitability challenges, though the sale price does not represent a particularly depressed valuation relative to recent trading ranges.

CLO Brown sold 500.0K shares (43.8% of holdings) at $15.21 on 2025-09-18; stock down 21.2% from 52-week high, company unprofitable FY.

Brian Michael Brown, Chief Legal Officer, sold 500,000 shares at $15.21, reducing his position from 1.14M to 640.3K shares (a 43.8% reduction). At the $15.75 current price, the trade was executed 3.5% above current levels but 21.2% below the 52-week high of $19.99. His prior AVPT sales show mixed timing outcomes: 2 of 3 measurable 90-day periods were well-timed (stock fell after sale), while 1 was poorly timed (stock rose 23.4% post-sale). The company reported $102.0M quarterly revenue with +21.6% annual growth, but remains unprofitable on a full-year basis. The magnitude of this sale—liquidating 43.8% of holdings in a single transaction—occurs against a backdrop of stock weakness (down 17.4% over 90 days) and persistent profitability challenges, distinguishing it from routine equity transactions.

Chief Legal Officer Brown sold 35,000 AVPT shares at $15.47 on 2025-08-25; stock now $15.80, down 14.0% in 30 days.

Brian Michael Brown, Chief Legal Officer, sold 35,000 shares (35.0K shares) at $15.47 on 2025-08-25, reducing his holdings from 1,190,443 shares to 1,155,443 shares. The transaction occurred as AVPT trades 21.0% below its 52-week high and has declined 14.0% over the past 30 days. Brown's cross-ticker track record shows prior sells were well-timed at a 33.33% rate with an average 90-day return of +7.4%, suggesting selective selling discipline; however, at AVPT specifically, his timing has been mixed—of 5 prior same-ticker sales, only 1 of 3 measurable at the 90-day horizon was well-timed. The company reported recent quarterly revenue of $102.0M with +21.6% annual growth, yet remains unprofitable on a full-year basis with net income of $2.9M in the latest quarter. This sale does not point to a clear conviction shift, but the continued downward price pressure and mixed prior timing at this ticker warrant monitoring of subsequent filings.

CLO Brown sold 35,000 AVPT shares at $18.74 on 2025-07-23; retains 1,190,443 shares post-sale

Chief Legal Officer Brian Michael Brown sold 35,000 shares (-2.9% of prior holdings) at $18.74, a price near but within the 52-week range of $9.70–$19.99. The stock is currently at $18.56, within 7.2% of its 52-week high. Brown's same-ticker history at AVPT shows mixed timing: his four prior sales included one notably well-timed sale on 2025-04-23 (which saw +20.6% 30-day and +23.4% 90-day returns, indicating he sold before strength) and three others with weaker or negative short-term outcomes, with 0 of 2 measurable 90-day outcomes showing sales before declines. The company posted recent quarterly revenue of $93.1M with net income of $3.6M, but remains unprofitable on an annual basis despite +21.6% annual revenue growth. This sale represents a modest reduction in a substantial 1.19M-share position, with no pattern clearly indicating predictive selling acumen at this ticker.

AVPT CLO Brian Michael Brown sold 35,000 shares at $18.23; retains 1.23M shares. Stock up 26.7% in 90 days; revenue growth strong at +21.6% but company unprofitable full-year.

Brown sold 35,000 shares (35.0K shares) of his 1.26M shares for $638.0K on 2025-06-23, reducing his stake by 2.8% while retaining substantial holdings of 1.23M shares. The sale occurred at $18.23, below the current price of $19.08 and 4.6% below the 52-week high, during a period of strong recent momentum (90-day return +26.7%, 30-day return +4.7%). His track record at AVPT shows mixed timing outcomes: two recent prior sales produced opposing outcomes (one +20.6% at 30 days, another -1.3% at 30 days), and his one measurable 90-day outcome at this ticker was well-timed (-2.0% at 30 days, +16.6% at 90 days). Fundamentals remain asymmetric—the company reported +21.6% annual revenue growth and $93.1M quarterly revenue, but was unprofitable on a full-year basis, limiting the strategic clarity of the sale relative to company trajectory. The modest reduction of a very large remaining position, combined with conflicting timing signals and underlying profitability uncertainty, suggests a routine portfolio action rather than a material signal.